vs
Side-by-side financial comparison of HALOZYME THERAPEUTICS, INC. (HALO) and ONESPAWORLD HOLDINGS Ltd (OSW). Click either name above to swap in a different company.
HALOZYME THERAPEUTICS, INC. is the larger business by last-quarter revenue ($451.8M vs $242.1M, roughly 1.9× ONESPAWORLD HOLDINGS Ltd). ONESPAWORLD HOLDINGS Ltd runs the higher net margin — 5.0% vs -31.3%, a 36.3% gap on every dollar of revenue. On growth, HALOZYME THERAPEUTICS, INC. posted the faster year-over-year revenue change (51.6% vs 11.5%). HALOZYME THERAPEUTICS, INC. produced more free cash flow last quarter ($217.6M vs $14.9M). Over the past eight quarters, HALOZYME THERAPEUTICS, INC.'s revenue compounded faster (51.9% CAGR vs 7.1%).
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
HALO vs OSW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $451.8M | $242.1M |
| Net Profit | $-141.6M | $12.1M |
| Gross Margin | 82.6% | — |
| Operating Margin | -20.6% | 6.8% |
| Net Margin | -31.3% | 5.0% |
| Revenue YoY | 51.6% | 11.5% |
| Net Profit YoY | -203.3% | -16.2% |
| EPS (diluted) | $-1.13 | $0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $451.8M | $242.1M | ||
| Q3 25 | $354.3M | $258.5M | ||
| Q2 25 | $325.7M | $240.7M | ||
| Q1 25 | $264.9M | $219.6M | ||
| Q4 24 | $298.0M | $217.2M | ||
| Q3 24 | $290.1M | $241.7M | ||
| Q2 24 | $231.4M | $224.9M | ||
| Q1 24 | $195.9M | $211.2M |
| Q4 25 | $-141.6M | $12.1M | ||
| Q3 25 | $175.2M | $24.3M | ||
| Q2 25 | $165.2M | $19.9M | ||
| Q1 25 | $118.1M | $15.3M | ||
| Q4 24 | $137.0M | $14.4M | ||
| Q3 24 | $137.0M | $21.6M | ||
| Q2 24 | $93.2M | $15.8M | ||
| Q1 24 | $76.8M | $21.2M |
| Q4 25 | 82.6% | — | ||
| Q3 25 | 84.4% | — | ||
| Q2 25 | 85.8% | — | ||
| Q1 25 | 81.7% | — | ||
| Q4 24 | 85.9% | — | ||
| Q3 24 | 83.0% | — | ||
| Q2 24 | 82.9% | — | ||
| Q1 24 | 85.5% | — |
| Q4 25 | -20.6% | 6.8% | ||
| Q3 25 | 61.5% | 10.2% | ||
| Q2 25 | 62.2% | 9.2% | ||
| Q1 25 | 53.4% | 7.7% | ||
| Q4 24 | 58.9% | 7.9% | ||
| Q3 24 | 56.3% | 10.3% | ||
| Q2 24 | 50.7% | 8.4% | ||
| Q1 24 | 48.8% | 8.0% |
| Q4 25 | -31.3% | 5.0% | ||
| Q3 25 | 49.5% | 9.4% | ||
| Q2 25 | 50.7% | 8.3% | ||
| Q1 25 | 44.6% | 7.0% | ||
| Q4 24 | 46.0% | 6.6% | ||
| Q3 24 | 47.2% | 8.9% | ||
| Q2 24 | 40.3% | 7.0% | ||
| Q1 24 | 39.2% | 10.0% |
| Q4 25 | $-1.13 | $0.12 | ||
| Q3 25 | $1.43 | $0.23 | ||
| Q2 25 | $1.33 | $0.19 | ||
| Q1 25 | $0.93 | $0.15 | ||
| Q4 24 | $1.06 | $0.13 | ||
| Q3 24 | $1.05 | $0.20 | ||
| Q2 24 | $0.72 | $0.15 | ||
| Q1 24 | $0.60 | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $133.8M | $16.3M |
| Total DebtLower is stronger | $2.1B | $84.0M |
| Stockholders' EquityBook value | $48.8M | $542.6M |
| Total Assets | $2.5B | $707.1M |
| Debt / EquityLower = less leverage | 43.89× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $133.8M | $16.3M | ||
| Q3 25 | $419.7M | $29.6M | ||
| Q2 25 | $61.9M | $35.0M | ||
| Q1 25 | $176.3M | $22.6M | ||
| Q4 24 | $115.8M | $57.4M | ||
| Q3 24 | $154.3M | $48.8M | ||
| Q2 24 | $187.9M | $62.5M | ||
| Q1 24 | $164.6M | $65.4M |
| Q4 25 | $2.1B | $84.0M | ||
| Q3 25 | $1.5B | $85.2M | ||
| Q2 25 | $1.5B | $96.2M | ||
| Q1 25 | $1.5B | $97.4M | ||
| Q4 24 | $1.5B | $98.6M | ||
| Q3 24 | $1.5B | $98.7M | ||
| Q2 24 | $1.5B | $123.8M | ||
| Q1 24 | $1.5B | $138.6M |
| Q4 25 | $48.8M | $542.6M | ||
| Q3 25 | $503.9M | $552.8M | ||
| Q2 25 | $332.7M | $548.3M | ||
| Q1 25 | $482.3M | $530.6M | ||
| Q4 24 | $363.8M | $554.5M | ||
| Q3 24 | $452.7M | $540.1M | ||
| Q2 24 | $289.4M | $532.7M | ||
| Q1 24 | $177.8M | $515.5M |
| Q4 25 | $2.5B | $707.1M | ||
| Q3 25 | $2.2B | $732.6M | ||
| Q2 25 | $2.1B | $731.8M | ||
| Q1 25 | $2.2B | $708.7M | ||
| Q4 24 | $2.1B | $746.4M | ||
| Q3 24 | $2.1B | $734.0M | ||
| Q2 24 | $2.0B | $756.8M | ||
| Q1 24 | $1.8B | $763.6M |
| Q4 25 | 43.89× | 0.15× | ||
| Q3 25 | 3.00× | 0.15× | ||
| Q2 25 | 4.54× | 0.18× | ||
| Q1 25 | 3.13× | 0.18× | ||
| Q4 24 | 4.14× | 0.18× | ||
| Q3 24 | 3.32× | 0.18× | ||
| Q2 24 | 5.19× | 0.23× | ||
| Q1 24 | 8.44× | 0.27× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $219.0M | $20.0M |
| Free Cash FlowOCF − Capex | $217.6M | $14.9M |
| FCF MarginFCF / Revenue | 48.2% | 6.2% |
| Capex IntensityCapex / Revenue | 0.3% | 2.1% |
| Cash ConversionOCF / Net Profit | — | 1.65× |
| TTM Free Cash FlowTrailing 4 quarters | $644.6M | $68.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $219.0M | $20.0M | ||
| Q3 25 | $178.6M | $33.2M | ||
| Q2 25 | $99.7M | $20.3M | ||
| Q1 25 | $154.2M | $10.1M | ||
| Q4 24 | $178.5M | $16.6M | ||
| Q3 24 | $115.4M | $28.6M | ||
| Q2 24 | $55.8M | $18.7M | ||
| Q1 24 | $129.4M | $15.0M |
| Q4 25 | $217.6M | $14.9M | ||
| Q3 25 | $175.6M | $27.6M | ||
| Q2 25 | $98.1M | $17.6M | ||
| Q1 25 | $153.3M | $8.4M | ||
| Q4 24 | $175.4M | $13.2M | ||
| Q3 24 | $113.9M | $27.5M | ||
| Q2 24 | $53.2M | $17.6M | ||
| Q1 24 | $125.9M | $13.7M |
| Q4 25 | 48.2% | 6.2% | ||
| Q3 25 | 49.6% | 10.7% | ||
| Q2 25 | 30.1% | 7.3% | ||
| Q1 25 | 57.9% | 3.8% | ||
| Q4 24 | 58.9% | 6.1% | ||
| Q3 24 | 39.3% | 11.4% | ||
| Q2 24 | 23.0% | 7.8% | ||
| Q1 24 | 64.3% | 6.5% |
| Q4 25 | 0.3% | 2.1% | ||
| Q3 25 | 0.9% | 2.2% | ||
| Q2 25 | 0.5% | 1.1% | ||
| Q1 25 | 0.4% | 0.8% | ||
| Q4 24 | 1.0% | 1.5% | ||
| Q3 24 | 0.5% | 0.5% | ||
| Q2 24 | 1.1% | 0.5% | ||
| Q1 24 | 1.8% | 0.6% |
| Q4 25 | — | 1.65× | ||
| Q3 25 | 1.02× | 1.36× | ||
| Q2 25 | 0.60× | 1.02× | ||
| Q1 25 | 1.31× | 0.66× | ||
| Q4 24 | 1.30× | 1.15× | ||
| Q3 24 | 0.84× | 1.33× | ||
| Q2 24 | 0.60× | 1.19× | ||
| Q1 24 | 1.68× | 0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HALO
| Royalty | $258.0M | 57% |
| Products | $122.7M | 27% |
| Proprietary Products Sales | $59.6M | 13% |
| Device Partnered Products | $12.9M | 3% |
OSW
| Services | $197.3M | 82% |
| Products | $44.8M | 18% |
